AbbVie forced to retract statements in $51 billion Shire bid

Drug maker AbbVie has run afoul of U.K. takeover rules and has had to pull back on its CEO’s comments that Shire shareholders are “generally supportive” of its takeover offer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.